Celltrion Healthcare

South Korean drug giant Celltrion Group has received a positive recommendation from Institutional Shareholder Services (ISS), a global leading proxy...

Celltrion Pharm Inc. announced on Wednesday that its pre-filled syringe (PFS) production facility in Cheongju, North Chungcheong Province has obtain...

South Korea's biopharmaceutical company Celltrion Inc. announced on Tuesday that it has secured approval from the Japanese Ministry of Health, Labou...

Celltrion Inc., a South Korean biopharmaceutical giant, said Monday it will provide biosimilars worth 423.6 billion won ($323.6 million), its larges...

South Korean food and beverage (F&B) company Samsung Welstory has teamed up with Kangbuk Samsung Hospital to develop business-to-business (B2B) ...

SK Chemicals Co., a South Korean plastic materials producer, is in exclusive talks with Seoul-based Glenwood Private Equity to sell its pharmaceutic...

South Korea's Hyundai Engineering & Construction (E&C) on Thursday announced its signing of a deal with Naver Cloud on cooperation in the de...

South Korea's Celltrion Healthcare Co. announced on Monday that it will supply its biosimilar Yuflyma (active ingredient: adalimumab) for the treatm...

South Korea's Lotte Healthcare has entered the digital healthcare market through the launch next week of its personalized healthcare management pl...

South Korea’s SK C&C on Tuesday signed an agreement to offer employee healthcare management programs to companies with digital healthcare ...

The use of data and computing is a new paradigm in the biopharmaceutical industry, reducing the new drug development time and cost, Celltrion Inc. C...

South Korean biopharmaceutical firm Celltrion Inc. announced on Tuesday that it plans to enlarge its finished pharmaceuticals manufacturing facility...

South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it has completed a patent agreement with Johnson & Johnson, the m...

South Korean drug giant Celltrion Group will consider listing its holding company if necessary, after it completes the merger of three affiliates &n...

South Korea’s Celltrion Healthcare Co. announced on Wednesday that it has signed contracts with 10 insurance providers in the US to boost the ...

South Korea’s DongKoo Bio & Pharma Co. on Tuesday said it signed a memorandum of understanding with the Philippine healthcare group Adizat...

South Korean biopharmaceutical company Celltrion Inc. announced on Tuesday that it has received approval from the European Medicines Agency (EMA) fo...

South Korean food giant CJ CheilJedang Corp. announced on Friday that it has signed a business agreement with Kakao Healthcare, a digital healthcare...

South Korean pharmaceutical giant Celltrion Group has begun procedures to merge biopharmaceuticals developer and producer Celltrion Inc. with global...

Kakao Healthcare Corp., a digital healthcare platform unit of South Korea's Kakao Corp., announced that it has signed on Tuesday a business agreemen...

South Korea’s telecom service provider KT Corp. has recently organized a collaborative seminar on digital health alongside Hanoi Medical Unive...

South Korea’s No. 1 biopharmaceutical company Samsung BioLogics Co. and No. 2 Celltrion Inc. produced higher CO2 emissions last year than in 2...

Canada's Ontario government has joined hands with a South Korean venture capital firm to establish a fund of 100 million Canadian dollars ($75.6 mil...

South Korean biopharmaceutical company Celltrion Healthcare on Monday said it launched the day before on the US market Yuflyma, a biosimilar of the ...

South Korean biopharmaceutical company Celltrion Inc. on Friday said it applied for approval from the US Food and Drug Administration (FDA) for CT-P...

Kakao Healthcare, a digital healthcare platform unit of South Korea's Kakao, announced on Wednesday that it has been selected as the final operato...

South Korea’s Kakao Healthcare Corp. has taken a step forward to expand its business into the global market by collaborating with US medical d...

South Korea’s Celltrion Inc. has put its Japanese Takeda Pharmaceutical Co.'s primary care assets acquired in 2020 on sale as the biosimilar g...

South Korea’s SK Biopharmaceuticals Co. has obtained the sales approval for its antiepileptic treatment Cenobamate in Canada, paving the way f...

South Korea's biopharmaceutical company Celltrion Inc. announced that it received on Thursday approval from the US Food and Drug Administration (FDA...